Redvax
Schlieren
About Redvax
Redvax is a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Redvax is a preclinical stage company. The company develops multi-component virus-like particles (VLPs) and other protein assemblies for vaccine development in the field of CMV and a further undisclosed field.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: M&A
- Last round: Series Unknown (Mar 2009)
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/redvax-1522910 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.